£11.5M
The financing round was led by Molten Ventures with backing from LifeX Ventures and private individuals.
IB
IMU Biosciences
IMU Biosciences builds a proprietary artificial intelligence platform for deep immune profiling and precision medicine.
London, UK—Founded 2021
£11.5MTotal raised
IMU Biosciences is a techbio company that combines deep immune profiling with proprietary artificial intelligence to map the human immune system. Its platform supports translational research, clinical diagnostics, drug development and personalised medicine across areas such as oncology and cell therapy.
Categories
Founders
AL
Adam Laing
CEO and Co-founder
TH
Tom Hayday
CSO and Co-founder
MC
Mario Cantero
Chief Operating Officer